| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |